58 related articles for article (PubMed ID: 9764798)
1. Bacterial lipopolysaccharide is a potent inhibitor of HIV-1 replication in T lymphocytes and macrophages.
Alfano M; Schmidtmayerova H; Bukrinsky M
AIDS; 1998 Sep; 12(13):1724-6. PubMed ID: 9764798
[No Abstract] [Full Text] [Related]
2. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
[TBL] [Abstract][Full Text] [Related]
3. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.
Moriuchi M; Moriuchi H; Turner W; Fauci AS
J Clin Invest; 1998 Oct; 102(8):1540-50. PubMed ID: 9788967
[TBL] [Abstract][Full Text] [Related]
4. Dapsone and HIV-1 replication in primary cultures of lymphocytes and monocyte-derived macrophages.
Duval X; Clayette P; Dereuddre-Bosquet N; Fretier P; Martin M; Salmon-Ceron D; Gras G; Vilde JL; Dormont D
AIDS; 1997 Jun; 11(7):943-4. PubMed ID: 9189230
[No Abstract] [Full Text] [Related]
5. IFN-gamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells.
Saïdi H; Magri G; Carbonneil C; Nasreddine N; Réquena M; Bélec L
J Leukoc Biol; 2007 Mar; 81(3):642-53. PubMed ID: 16971466
[TBL] [Abstract][Full Text] [Related]
6. LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons.
Simard S; Maurais E; Gilbert C; Tremblay MJ
Clin Immunol; 2008 May; 127(2):198-205. PubMed ID: 18295544
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide stimulates HIV-1 entry and degradation in human macrophages.
Pushkarsky T; Dubrovsky L; Bukrinsky M
J Endotoxin Res; 2001; 7(4):271-6. PubMed ID: 11717580
[TBL] [Abstract][Full Text] [Related]
8. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
9. Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity.
Liu X; Mosoian A; Li-Yun Chang T; Zerhouni-Layachi B; Snyder A; Jarvis GA; Klotman ME
J Infect Dis; 2006 Sep; 194(6):751-9. PubMed ID: 16941340
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
Wang J; Guan E; Roderiquez G; Norcross MA
J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
[TBL] [Abstract][Full Text] [Related]
11. Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages.
Song H; Nakayama EE; Shioda T
AIDS; 2006 Apr; 20(6):937-9. PubMed ID: 16549982
[TBL] [Abstract][Full Text] [Related]
12. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and HIV replication.
Schmidtmayerova H; Sherry B; Bukrinsky M
Nature; 1996 Aug; 382(6594):767. PubMed ID: 8752270
[No Abstract] [Full Text] [Related]
14. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine.
Cota M; Mengozzi M; Vicenzi E; Panina-Bordignon P; Sinigaglia F; Transidico P; Sozzani S; Mantovani A; Poli G
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9162-7. PubMed ID: 10908681
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 and the host cell: an intimate association.
Freed EO
Trends Microbiol; 2004 Apr; 12(4):170-7. PubMed ID: 15051067
[No Abstract] [Full Text] [Related]
16. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection.
Lawn SD; Pisell TL; Hirsch CS; Wu M; Butera ST; Toossi Z
J Infect Dis; 2001 Nov; 184(9):1127-33. PubMed ID: 11598835
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages.
Jiang Y; Jolly PE
J Hum Virol; 1999; 2(3):123-32. PubMed ID: 10413363
[TBL] [Abstract][Full Text] [Related]
18. Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes.
Cara A; Guarnaccia F; Reitz MS; Gallo RC; Lori F
Virology; 1995 Apr; 208(1):242-8. PubMed ID: 11831706
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells.
Chen J; Rhodes TD; Hu WS
J Virol; 2005 Jul; 79(14):9337-40. PubMed ID: 15994830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
